Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™ at BPI Boston 2022 2022-09-29 19:00
NeuShen Therapeutics Closes Pre-A Financing with ~$20M 2022-09-29 17:50
Kintor Pharma Announces Publication of Phase Ib Data from Pruxelutamide for AR+ mBC in EJC 2022-09-29 14:22
Simcere and Almirall Enter into a Licensing Agreement for IL-2 mu-Fc 2022-09-29 11:32
GC Labs becomes the first Korean laboratory to obtain certification of CDC standardization programs (VDSCP & HoSt) 2022-09-29 08:17
Zhongchao Inc. Establishes Chongqing Xinjiang Pharmaceutical Co., Ltd. to Improve Patient Access to Medications 2022-09-28 21:18
First-Ever Spinal Surgical Hand-held Robot by Point Robotics MedTech to Make Its Worldwide Debut in the United States 2022-09-28 21:01
Samsung Biologics Earns Gold Rating from EcoVadis for Its Sustainability Efforts 2022-09-28 19:00
Portfolio Highlights: Clinical and Financial Updates of ABM, F5, AceLink, HAYA, Regenacy, and Arthrosi 2022-09-28 18:31
The 6th China (Shenzhen) Innovation & Entrepreneurship International Competition Eindhoven, Netherlands Division is Open for Registration 2022-09-28 17:55
EmeTerm Anti-Nausea Wristband Undergoes Clinical Study for Prevent of Postoperative Nausea and Vomiting 2022-09-28 01:15
Harbour BioMed Announces First Subject Dosed in Phase I Study of Next-Gen Anti-TSLP Fully Human Monoclonal Antibody 2022-09-27 21:40
Neurophth announces first patient dosed in Phase III clinical trial for the gene therapy treatment of LHON 2022-09-27 20:30
Angel Pharmaceuticals Announces Approval of IND Application for Phase 1/1b Clinical Trial of Mupadolimab (Anti-CD73) in China 2022-09-27 08:30
Fosun Pharma and MAIA Pharmaceuticals Jointly Announce the Successful Commercialization of Only FDA Approved 20ml Sodium Phenylacetate and Sodium Benzoate (SPSB) Liquid Product 2022-09-26 22:13
Bioheng Biotech Announces Publication of Impressive Results with CD7-targeted allogeneic CAR-T cell therapy for Relapsed or Refractory T Cell Malignancies 2022-09-26 21:00
WuXi STA Opens First High Potency Oral Drug Product Manufacturing Facility 2022-09-26 20:00
PharmAbcine to Participate in BIO-Europe 2022 2022-09-26 20:00
Alterity Therapeutics Announces Presentation of Wearable Sensor Data from the bioMUSE Natural History Study at the International Congress of Parkinson's Disease and Movement Disorders 2022-09-26 19:25
CellOrigin Biotech Announces Global Strategic Collaboration with Qilu Pharma to Develop "Off-the-Shelf" CAR-iMAC Cell Therapy 2022-09-26 12:31
1 126 127 128 129 130 801